# Role of Exenatide in Type 1 Diabetes

> **NCT00456300** · PHASE2 · COMPLETED · sponsor: **Montefiore Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT00456300
- **Lead sponsor:** Montefiore Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2019-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00456300

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00456300, "Role of Exenatide in Type 1 Diabetes". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT00456300. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*